Palisade Bio Price To Earning vs. Price To Book

PALI Stock  USD 2.46  0.04  1.65%   
Considering Palisade Bio's profitability and operating efficiency indicators, Palisade Bio may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Palisade Bio's ability to earn profits and add value for shareholders. The current Price To Sales Ratio is estimated to decrease to 17.64. The current Days Sales Outstanding is estimated to decrease to 236.07. As of now, Palisade Bio's Net Income Per E B T is increasing as compared to previous years.
For Palisade Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Palisade Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Palisade Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Palisade Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Palisade Bio over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(13.26)
Return On Assets
(0.59)
Return On Equity
(1.10)
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Palisade Bio Price To Book vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Palisade Bio's current stock value. Our valuation model uses many indicators to compare Palisade Bio value to that of its competitors to determine the firm's financial worth.
Palisade Bio is regarded third in price to earning category among its peers. It is rated below average in price to book category among its peers fabricating about  3.50  of Price To Book per Price To Earning. The current Price To Book Ratio is estimated to decrease to 0.34. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Palisade Bio's earnings, one of the primary drivers of an investment's value.

Palisade Price To Book vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Palisade Bio

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
0.16 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Palisade Bio

P/B

 = 

MV Per Share

BV Per Share

 = 
0.56 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Palisade Price To Book Comparison

Palisade Bio is currently under evaluation in price to book category among its peers.

Palisade Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Palisade Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Palisade Bio will eventually generate negative long term returns. The profitability progress is the general direction of Palisade Bio's change in net profit over the period of time. It can combine multiple indicators of Palisade Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-13.1 M-13.7 M
Income Before Tax-12.3 M-12.9 M
Total Other Income Expense Net770 K808.5 K
Net Loss-12.3 M-12.9 M
Income Tax Expense16 K16.8 K
Interest Income25.9 K24.6 K
Net Loss-13.1 M-13.7 M
Net Interest Income-15 K-15.8 K
Net Loss-12.3 M-12.9 M
Change To Netincome16.4 M17.2 M
Net Loss(26.97)(28.32)
Income Quality 0.91  0.61 
Net Income Per E B T 1.03  1.09 

Palisade Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Palisade Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Palisade Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Palisade Bio's important profitability drivers and their relationship over time.

Use Palisade Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Palisade Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palisade Bio will appreciate offsetting losses from the drop in the long position's value.

Palisade Bio Pair Trading

Palisade Bio Pair Trading Analysis

The ability to find closely correlated positions to Palisade Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Palisade Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Palisade Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Palisade Bio to buy it.
The correlation of Palisade Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Palisade Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Palisade Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Palisade Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Palisade Bio position

In addition to having Palisade Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:
Check out Your Equity Center.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
To fully project Palisade Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Palisade Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Palisade Bio's income statement, its balance sheet, and the statement of cash flows.
Potential Palisade Bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Palisade Bio investors may work on each financial statement separately, they are all related. The changes in Palisade Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Palisade Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.